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Introduction
Cutaneous Leishmania (CL) skin defects lasting for >6
weeks1 similar to chronic wounds of the elderly in
developed countries are prevalent in Afghanistan2 in
uncovered body parts mostly of young children after
their first contact with the parasite through a sand-fly
bite. From two phase II CL trials3,4 it appears that clean
CL wound management is crucial for rapid healing.
Objectives
As alcohol-based hand-rubs (ABHR) were not available in
Afghanistan5 in 2012 when signing the WHO pledge6 to
reduce the burden7 of the CL disease, we wanted to foster
the local low-price ABHR production by involving the
Pharmaceutical Faculty on the new Campus (PharmFac).
Methods
In the absence of PharmFac labs, we used the lab of the
renovated leishmania centre of the Balkh Civil Hospital,
which two of us had (DP & KWS) audited in 2012. We
trained the students on the job of producing ABHR
according to the WHO guide using the WHO starter kit8.
To prepare 3 batches of 100 ml ABHR bottles we had to
buy the ingredients of WHO formula 1 on the Mazar
bazaar.
Results
The students, who participated in the daily leishmania
wound patients’ consultations, were highly motivated,
when they understood the importance of hand-hygiene in
this field. They were enthusiastic about their first opportu-
nity of pharmaceutical bench work. They were hugely dis-
appointed, when the later quality control at the HUG
Pharmacy in Geneva revealed that two flasks of “Ethanol
absolut” had been adulterated with methanol, up to 50
and 80% respectively, and that they had to destroy all 150
ABHR flasks on the spot. In 2014 ABHR leftover stocks of
the US Army had engulfed the bazaar of Mazar at 1/2.6
USD per litre (October 2014/February 2015). The tempor-
ary economic ABHR availability might explain the hand
hygiene awareness and practice we observed in the Balkh
Civil Hospital in contrast to what we had experienced
in 2012.
Conclusion
Economic ingredients of guaranteed quality constitute the
bottleneck for ABHR production in poor countries, not
the motivation of pharmaceutical students. Those, who
feel concerned, are invited to discuss such issues with us.
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